Pioneering
1st Clinical Recommended
Pharmacogenomics (PGx)*
*Awarded by the Malaysian Book of Records
Death of 13-Day-Old
Full-term Healthy Baby Boy
Based on a true story, how a Pharmacogenomics test could have prevented a tragedy. A preventable death of a 13-day-old baby as reported by Koren G. et al. in 2006. The baby died due to a high concentration of morphine from the breast milk. The mom was unaware her DNA (Ultra rapid metaboliser) would convert the codeine-based painkiller medicine into an overly high morphine level in her blood and eventually pass through the breast milk to the baby.¹
¹ Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006 Aug 19; 368(9536):704.
6ᵗʰ
Leading cause of death due to Medication Side Effects
or Adverse Drug Reactions ²
~70%
Of physicians opt to modify drugs or dosages using Pharmacogenomics (PGx) ³
~30%
Reduction in Adverse Drug Reaction cases with pharmacogenomics-guided prescription ³
² Montastruc JL, Lafaurie M, de Canecaude C, et al. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. Br J Clin Pharmacol. 2021;87(11):4334-4340.
³ Swen JJ, van der Wouden CH, Manson LE, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401(10374):347-356.
introducing
PRECISE Pharmacogenomics
Using Genome-wide technology, we can determine how genetic information affects your body’s response to medication through our DNA Test Kit. Our DNA report supports clinicians in providing Clinical Recommendations and Personalized Targeted Treatments. Find out more about 1st Clinical Recommended Genome-wide Pharmacogenomics, PRECISE Pharmacogenomics!
- Covers more than 1,000 genes & 500+ commonly prescribed medication
- 20+ Therapeutics Areas
- Clinical Accredited & Recommended
- Maximise & Optimise Medication Effectiveness
awarded by
the malaysia book of records
Precision Diagnostics is awarded for the ‘1ˢᵗ Clinical Recommended for Genome-Wide Pharmacogenomics” since 2023.
Featured Article
Pioneering 1ˢᵗ Malaysian Pharmacogenomics Summit
1st Malaysia Pharmacogenomics Summit 2024
The 1st Malaysia Pharmacogenomics (PGx) Summit 2024 was co-chaired, organized, and sponsored by Global Precision Diagnostics under the leadership of its CEO – a leading pharmacogenomics testing laboratory in Malaysia, accelerating the integration of pharmacogenomics into clinical practice. This summit laid the foundation for a new era in healthcare, leading to strong collaboration between government bodies, healthcare professionals, and industry leaders.
OUR SERVICES
Specialised in Molecular Genetics
We at Precision Diagnostics, provide clinically accredited services to advance patient care in genomics, especially through their DNA. Recognized by the Malaysia Book of Records, we are Malaysia’s First Clinical Recommended Genome-Wide Pharmacogenomics provider since 2023.
Buccal Swab Instructions
Instruction videos on how use our Buccal Swab and available in (3) three languages.
Better Health through your DNA
Your healthcare becomes as unique as your DNA, ensuring that the medications you take are tailored to your specific needs. Discover how this cutting-edge science can improve your treatment outcomes and help you achieve better health.
Genome-wide Technology
By examining your genetic makeup, we identify which medications will work best for you, which ones might cause side effects, and what the right dosage should be.
Testimonials
What Our Clients Say About Us
Precision Diagnostics is grateful for our patients‘ or clients‘ testimonies as our tests reflect on the trust and collaboration that we have built with our partners, whereby highlighting the value and impact of our service towards the community.
TRANSFORMING LIVES
Our Collaborators & Partners
Newsletter & Blogs
Check out our recent events, news and online blogs
About Us
Precision Diagnostics' laboratory workflows and pipelines are meticulously designed, incorporating both internal and external validations, and quality controls to comply with various international guidelines and standards, including Good Laboratory Practice (GLP), ISO 15189, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP). Additionally, the laboratory participates in external quality assurance and proficiency programs and the College of American Pathologists (CAP).
